Top Stories
- Prepare to resume evaluating for RSV vaccination during pregnancy in September; plan for RSV immunization of older infants and high-risk children in October
- “Vaccination Coverage Among Adolescents Aged 13–17 Years—National Immunization Survey-Teen, United States, 2024” published in MMWR
- Immunize.org statement of support for CDC staff
- FDA approves updated labeling for live-attenuated chikungunya vaccine (Ixchiq, Valneva) with new clinical considerations and warnings for people age 60 and older
- When may people younger than age 65 years receive high-dose or adjuvanted influenza vaccine? Watch the 2-minute answer, part of the Ask the Experts Video Series on YouTube.
- Vaccines in the news
Immunize.org Website and Clinical Resources
- Spotlight on the LetsGetRealAboutVaccines.org website: “Separate Fact from Fiction”
- Recap: Immunize.org posts “Influenza Vaccine Products for the 2025–2026 Influenza Season”
- Recap: Immunize.org issues updated standing orders template for RSV vaccination of older adults to include high-risk adults age 50 through 74 years
- Recap: Immunize.org updates “Standing Orders for Administering Recombinant Zoster Vaccine (Shingrix) to Adults” template to include manufacturer-filled syringe option
- Recap: Immunize.org updates “Checklist of Current Versions of U.S. COVID-19 Vaccination Guidance and Clinic Support Tools”
Upcoming Events